Cardiff Presents Positive Phase 2 Data For Onvansertib In Colorectal Cancer, Highlights 72% ORR

India, June 2 -- Cardiff Oncology Inc. (CRDF), a clinical-stage biotechnology company, on Tuesday announced positive Phase 2 results for Onvansertib in combination with standard-of-care regimens in tr... Read More

Relay Therapeutics Shares Jump 18%

India, June 2 -- Relay Therapeutics, Inc. (RLAY) stock surged 18.21 percent to $16.86, gaining $2.60 on Tuesday, marking a sharp upward move despite no company-specific news. The stock is currently t... Read More

Rezolute Reports Positive Interim Data In Phase 3 UpLIFT Study For Ersodetug For Tumor HI

India, June 2 -- Rezolute Inc. (RZLT), a late-stage company focused on ultra-rare diseases, announced positive interim results from its ongoing Phase 3 upLIFT study of Ersodetug in patients with tumor... Read More

Pasithea's PAS-004 Receives FDA Orphan Drug Designation In Treating AL. Sclerosis

India, June 2 -- Pasithea Therapeutics Corp. (KTTA), a clinical-stage biotechnology company, announced it has received Orphan Drug Designation for PAS-004 in treatment of Amyotrophic Lateral Sclerosis... Read More

Manchester Orchestra Release Live Album 'Union Chapel, London, England'

India, June 2 -- Manchester Orchestra have released a new live album, Union Chapel (London, England), via Loma Vista Recordings. In a personal letter shared with fans, Manchester Orchestra's Andy Hul... Read More

Candel Publishes Phase 3 Results For Aglatimagene In Treating Prostate Cancer, Notes Improved DFS

India, June 2 -- Candel Therapeutics Inc. (CADL), a clinical-stage biopharmaceutical company, on Tuesday announced encouraging results from the Phase 3 trial for Aglatimagene in treating high-risk loc... Read More

Alibaba Gains 5% On Manulife AI Partnership In Hong Kong

India, June 2 -- Shares of Alibaba Group Holding Limited (BABA) gained 5% after Manulife Hong Kong announced a strategic partnership with Alibaba Cloud to advance AI adoption in the insurance sector. ... Read More

CELC Shares Fall 22% Following VIKTORIA-1 Clinical Trial Results

India, June 2 -- Celcuity Inc. (CELC) stock fell 22.41 percent to $95.41, losing $27.55 on Tuesday, despite announcing detailed positive efficacy data from the PIK3CA mutant cohort of its Phase 3 VIKT... Read More

U.S. Stocks Showing Modest Move To The Upside

India, June 2 -- Stocks continue to show a lack of direction during trading on Tuesday but have maintained the positive bias seen over the two previous sessions. While buying interest seems somewhat s... Read More

Co-Diagnostics And CoSara Advance Development Of Ebola PCR Test And Point-of-Care Platform; Stock Up

India, June 2 -- Co-Diagnostics Inc. (CODX) and its joint venture CoSara Diagnostics Pvt. Ltd. announced progress in developing a PCR-based diagnostic test for Ebola virus, alongside enhancements to t... Read More

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»